Objective: To investigate whether greater cardiorespiratory fitness is associated with better global and domain-specific cognitive function.
Physical activity 1 and cardiorespiratory fitness 2 have been previously associated with cognitive function in the elderly, and the reduction of Alzheimer and Parkinson disease risk. 3 Nevertheless, there is a substantial amount of variability in the results linking cognitive performance to physical activity because of heterogeneity in the assessments across the studies. 4 While physical activity and cardiorespiratory fitness are intertwined, their relationships with cognitive performance may be distinct from another. Cardiorespiratory fitness is frequently assessed as the maximum oxygen consumption (VȮ 2 max), which progressively declines with age, 5 but can be increased by prolonged exercise even in the elderly. 6 Cross-sectional observational studies in the elderly found a protective effect of VȮ 2 max on memory 7 and executive function. 8 Similarly, exercise interventional trials improving VȮ 2 max reported improvements in executive function 9 and short-term memory. 10 The mechanism linking higher VȮ 2 max to cognition is, however, not well understood. Neuroprotective or -generative effects, 11 improvements in cerebrovascular function, 12 and indirect effects through a healthier lifestyle 13 have been implicated.
Comprehensive studies investigating the association between VȮ 2 max and cognition in the elderly are sparse. 14 Therefore, we studied the effect of VȮ 2 max on both global and domainspecific cognitive function in 877 elderly individuals of the Austrian Stroke Prevention Study who underwent exercise ECG, neuropsychological testing, and brain MRI. We also tested whether the effect of VȮ 2 max on cognitive functions is mediated by MRI correlates of brain aging, such as white matter lesions (WMLs), brain parenchymal fraction (BPF), and lacunes.
METHODS Study population. The Austrian Stroke Prevention Study is a community-based cohort study on the effects of vascular risk factors on brain structure and function in elderly participants without a history or signs of stroke and dementia on the inhabitants of Graz, Austria. 15, 16 Study characteristics can be found in table 1. The participation rate was 32.4%. Telephone interviews with 200 random nonresponders yielded no significant differences to responders regarding demographics and frequency of vascular risk factors known to the participants.
The current study cohort comprised 877 participants from 2 panels (1991-1994 and 1999-2003) . A subset of 762, 782, and 594 participants additionally underwent MRI measures for WML volume, BPF, and lacunes, respectively. APOE genotype was available for a subset of 780 participants.
Clinical history, blood tests, MRI, cognitive testing, and exercise ECG were done on the same day. Smoking status was coded as current, former, or never, and participants were considered current smokers if they smoked .10 cigarettes a day. Body mass index (BMI) was calculated in kilograms per square meter. Total cholesterol was determined using a commercially available kit (MA-Kit 100; Hoffmann-La Roche, Basel, Switzerland). Hypertension was considered present if repeated blood pressure was $160/95 mm Hg or if participants received medication. Diabetes was considered present if fasting blood glucose levels exceeded 140 mg/dL or participants received medication. 15, 16 Assessment of metabolic syndrome and cardiovascular disease is described elsewhere. 17, 18 Standard protocol approvals, registrations, and patient consents. We received approval from the local standard ethics committee of the Medical University of Graz for experiments using human participants. Written informed consent was obtained from all study participants.
Exercise protocol. All participants completed a graded exercise stress test on a treadmill ergometer (General Electric Case V6) supervised by a cardiologist. None of the participants who underwent exercise ECG had clinical or ECG evidence for myocardial infarction or atrial fibrillation.
The protocol consisted of progressive increments of 25 W at 2-minute intervals. According to standard guidelines, reasons for breakoff were occurrence of angina pectoris or dyspnea, ECG ST segment changes, malignant arrhythmias, hypertension .240 mm Hg systolic blood pressure, or achievement of maximum heart rate. The stress tests were performed in the morning hours. Heart rate and blood pressure were measured in sitting position at rest and during exercise in 2-minute intervals. ECG was recorded continuously. Mass-specific VȮ 2 max was calculated by the following formula: (15 mL$kg 21 $min 21 ) 3 maximum/resting heart rate. 19 Cognitive testing. A test battery assessing the cognitive domains of memory, motor skills, and executive function was administered as described previously 15, 16 and references are listed in appendix e-1 on the Neurology ® Web site at Neurology.org.
To evaluate memory, a test called Bäumler's Lern-und Gedächtnistest (LGT) was used. Motor skills were evaluated by the Purdue Pegboard Test. Executive function was assessed by the Wisconsin Card Sorting Test, Trail Making Test-Part B, and Digit Span Backward, which is part of the Wechsler Adult Intelligence Scale-Revised, the Alters Konzentrationstest, and a computerized complex reaction time task (Wiener Reaktionsgerät), which is part of the Schuhfried psychological test battery.
Summary measures of cognitive functions were calculated by converting test results to z scores and computing the average scores within each cognitive domain. The z scores were not adjusted for age, sex, and education.
We additionally calculated a measure of global cognitive ability from all cognitive domains. 20 The listwise n was 765 and the Pearson correlation factor among the 7 tests ranged from 0.130 to 0.531, with a mean of 0.331. Principal components analysis was applied to the 7 tests. The first unrotated principal component accounted for 42.9% of the total test variance and was used as the global cognition in our subsequent analyses. Loadings on the first unrotated principal component were as follows: Alters Konzentrationstest, 1 5 20.538; figural memory (LGT), 2 5 0.646; verbal memory (LGT), 3 5 0.730; complex reaction time task, 4 5 20.541; Digit Span Backward, 5 5 0.594; Purdue Pegboard Test, 6 5 0.723; and Trail Making Test-Part B, 7 5 20.771. Presence of lacunes, n (%) 42 (5) Abbreviations: BMI 5 body mass index; BPF 5 brain parenchymal fraction; IQR 5 interquartile range; WML 5 white matter lesion.
MRI. All MRI scans were performed on 1.5T supraconducting magnets (Gyroscan S 15 and ACS; Philips, Eindhoven, the Netherlands) using proton density-and T2-weighted sequences (repetition time [TR]/echo time [TE] 5 2,000-2,500 milliseconds [ms]/30-90 ms) in the transverse orientation and T1-weighted images (TR/TE 5 600/30 ms) in the sagittal plane. The slice thickness was 5 mm and the matrix size was 128 3 256 pixels. An axial fluid-attenuated inversion recovery sequence (TR 5 10,000 ms, TE 5 69 ms, inversion time 5 2,500 ms, number of slices 5 40, slice thickness 5 3 mm, inplane resolution 5 0.86 3 0.86 mm) was added to the initial magnetic resonance protocol in the second study phase between 1999 and 2003. Assessment of brain abnormalities was only done on the dual-echo T2-weighted but not on fluid-attenuated inversion recovery scans to rely on identical MRI sequences throughout the study. For WML volume measurements, the scans were analyzed by 2 experienced investigators who were blinded to clinical data of study participants. WMLs were graded according to our scheme. All punctate early confluent and confluent WMLs in the deep and subcortical white matter and periventricular WMLs irregularly extending into the deep white matter were marked and outlined on a transparency that was overlaid on the proton density scan. Periventricular caps, pencil-thin lining, and periventricular halos were not included for WML volume measurement as these changes are considered to be of nonischemic origin.
Independent from visual analysis, lesion load measurements were done on proton density-weighted images on an Ultra-SPARC workstation (Sun Microsystems, Santa Clara, CA) by a trained operator using DISPImage. The operators used a hardcopy overlaid by the transparency, with each single lesion outlined by the experienced readers as reference. Every single lesion was segmented on the computer image, and its area was provided by the semiautomated thresholding algorithm implemented in DISPImage. Each lesion volume was calculated by multiplying the area by slice thickness. Total WML volume in cubic millimeters was the sum of volumes of single lesions in a given study participant.
Lacunes were defined as focal lesions that involved the basal ganglia, internal capsule, thalamus, or brainstem, not exceeding a diameter of 15 mm.
Brain volume was calculated from the T2-weighted spin-echo sequence using the automated structural image evaluation of atrophy (SIENAX, part of the FMRIB Software Library; http://www. fmrib.ox.ac.uk/fsl). BPF was estimated from the ratio of parenchymal volume to the total volume given by the outer surface of the brain.
To determine the measurement errors in our dataset, 20 participants were scanned and rescanned after shortly leaving the scanner. The median relative error for SIENAX was 1.2%.
Statistical analysis.
Only cases with no missing data were included in the analyses. Normal distributions were tested with the Kolmogorov-Smirnov test and evaluation of quantilequantile plots. WML volume had a skewed distribution containing zero values and therefore the value 1 was added before natural log transformation.
We assessed the relationship between VȮ 2 max and cognition in 2 linear regression models. Model 1 was adjusted for age, sex, years of education, and treatment with Ca 21 channel antagonists or b-blockers. Model 2 additionally incorporated vascular risk factors, namely, hypertension, diabetes, total cholesterol, smoking status, and BMI. Sources of potential bias include the indirect assessment of VȮ 2 max and residual confounding through unaccounted lifestyle variables.
To assess the association between VȮ 2 max and WMLs, lacunes, and BPF, linear regression models including the same set of covariates, except for years of education, were performed. Multicollinearity was assessed between the independent variable VȮ 2 max and the confounders in the models using the variance inflation factor. The mean variance inflation factor was 1.250 with values ranging from 1.052 to 1.938, therefore no covariates had to be excluded from the models. For each regression coefficient, the 95% confidence interval and p value were determined. A 2-tailed p value ,0.05 was considered to be statistically significant.
To test the hypothesis that VȮ 2 max effects on cognition are mediated by MRI findings, we used simple bootstrapped mediation models for estimating indirect effect sizes using PRO-CESS. 21 Mediation was assessed for each of the MRI measures individually.
In addition, stratified analysis was performed using the median for age, binary carrier status for APOE e4, as well as 3 groups for BMI (#25, 26-29, and $30 kg/m 2 ). Interaction terms of age, APOE e4, and BMI were calculated by multiplying the variables individually with VȮ 2 max and added to model 2 of the regression to investigate interaction effects.
To determine possible dose-effect relationships of significant associations between VȮ 2 max and cognitive outcomes, participants were categorized into VȮ 2 max quartiles. Linear regression analyses with VȮ 2 max quartiles and cognitive measures adjusted for confounders similar to model 2 were performed, in which the lowest quartile of VȮ 2 max values served as the reference. A p value for the trend was calculated by including the quartiles as a continuous variable in the model.
Because of the explorative nature of the study, no corrections for multiple testing were made. 22 RESULTS Higher VȮ 2 max was associated with better global and domain-specific cognition after adjustment for age, sex, and education, and Ca 21 and b-blocker use (table 2). Addition of vascular risk factors in model 2 had no effect on our observations, with the exception of motor skills, which was no longer associated.
Subsequently, we investigated whether the effect of VȮ 2 max on cognition was mediated by the presence of lacunes, WML volume, and BPF (table 3) , but found no evidence for this assumption. As we previously reported, absolute VȮ 2 max was associated with volume of WMLs in our cohort, but not with lacunes or BPF (table e-1). 23 Next, we assessed whether the association between VȮ 2 max and cognition was restricted to subgroups, by stratifying for age, BMI, and APOE e4 carrier status, which revealed a confined effect in younger participants (aged #65 years), participants with lower BMI (#25 kg/m 2 ), and in APOE e4 noncarriers (table 4) .
Formal test for interactions for memory, executive function, and global cognition were not significant for either age (B 5 20.01, p 5 0.084; B 5 0.000, p 5 0.254; B 5 0.000, p 5 0.999) or APOE e4 carrier status (B 5 0.000, p 5 0.883; B 5 20.002, p 5 0.105; B 5 20.002, p 5 0.370).
We observed an interaction between VȮ 2 max and BMI on memory, but not executive function or global cognition (B 5 20.003, p 5 0.043; B 5 20.001, p 5 0.450; B 5 20.001, p 5 0.412).
We further explored the association between VȮ 2 max and cognition by analyzing the effect of quartiles of the VȮ 2 max distribution (figure) and discovered a linear trend with memory, executive function, as well as global cognition.
The differences in effect sizes between the lowest and the highest quartile of VȮ 2 max were 0.298 for memory, 0.117 for executive function, and 0.260 for global cognition. Given that 1 year of age changes the z score by 20.045 for memory, by 20.018 for executive function, and by 20.066 for global cognition, individuals in the highest quartile of VȮ 2 max obtained memory, executive function, and global cognition results typical for participants being 6, 7, and 4 years younger than those belonging to the lowest VȮ 2 max quartile. DISCUSSION In the present study, higher VȮ 2 max was associated with better global cognition, as well as with better performance in memory, executive function, and motor skills.
The differences in cognitive performance between participants in the highest vs lowest quartile of VȮ 2 max corresponded to an age difference of 4, 6, and 7 years for global cognition, memory, and executive function. Given that the incidence of Alzheimer disease is increasing exponentially from about 0.5% in the age group of 65-70 years to approximately 6%-8% for individuals older than 85 years by doubling every 5 years, these effect sizes can be considered as large and potentially relevant for preventing or delaying dementia. 24 The effect of fitness both on global cognition as well as on the specific cognitive domains suggests that better fitness may slow down the process of brain aging in general. In line with this hypothesis, a recent review summarizing the association between physical activity, cardiorespiratory fitness, and dementia concludes that the brain indeed preserves its plasticity to respond to physical activity into late adulthood and that even modest physical activity can reduce the risk of dementia. 25 Clearly, well-controlled and long-term randomized interventional trials measuring incidence of dementia are needed to formally test this hypothesis.
The widespread effect of VȮ 2 max on cognition lets us hypothesize that both cortical and subcortical structures are protected by higher VȮ 2 max. However, we found no mediation of the association by brain atrophy, WMLs, or lacunes in our cohort to support this hypothesis.
Nevertheless, we cannot rule out that microstructural changes, undetectable by conventional MRI, are acting as mediators. Indeed, cross-sectional studies showed an association between microstructural integrity of both normal and hyperintense white matter with cognitive function, regardless of WML volume or brain atrophy, 26 and also reported higher integrity of white matter in physically active individuals. 27 A 12-month aerobic exercise intervention program observed changes in white matter integrity concomitant with improvement in short-term memory. 10 Table 2 Linear regression analyses of the association of VȮ 2 max with cognitive measures By stratifying on strong risk factors for dementia, we found that the associations between VȮ 2 max and cognitive functions were restricted to the middleaged (younger than 65 years), to APOE e4 noncarriers, and to nonobese individuals. Upon formal testing, we only found an interaction between VȮ 2 max and BMI in the memory domain. Therefore, we can conclude that the effect of VȮ 2 max on cognitive outcomes is not modulated by age or APOE e4 carrier status. BMI, however, showed a modulating effect on the association between VȮ 2 max and memory (p 5 0.043).
Previous studies reported contradictory findings on the modulating effect of strong risk factors. A meta-analysis of intervention trials concluded that older participants (.65 years) benefit more than younger ones from enhancing their fitness. 28 While we found no studies investigating APOE in a similar setup, a cross-sectional study in the healthy elderly found that poor midlife physical activity is associated with increased risk of developing dementia only in APOE e4 noncarriers. 29 According to a cross-sectional investigation, the beneficial effect of VȮ 2 max on cognition and regional brain volume was confined to obese individuals. 30 The contradictory findings may be partly explained by the relatively small sample sizes, differences in study design, observational vs interventional, and by differences in the characteristics of the individuals investigated.
In the interventional trials, only seniors who were sedentary at baseline were included. Therefore, only a relatively short-term effect of fitness improvements on cognition could be examined compared to observational studies in which a higher average fitness level is likely due to prolonged commitment to regular exercise and/or to beneficial genetic factors. This is well in line with recent findings of the longitudinal CARDIA study that higher cardiorespiratory fitness in midlife is associated with better performance in psychomotor speed and verbal memory 25 years later. 31 In the present study, we used VȮ 2 max as a measure of cardiorespiratory fitness, which represents the maximum capacity of the pulmonary, cardiovascular, and skeletal muscle to uptake, transport, and utilize oxygen during severe exercise. 32 The interindividual variation in VȮ 2 max is mainly attributable to differences in maximum cardiac output. 32 VȮ 2 max itself, as well as its response to exercise, shows a considerable heritability of 25% to 65%. 33 Endurance training can significantly increase VȮ 2 max, but again large variations between individuals in response to training are present 28 : the improvement of VȮ 2 max by endurance training is primarily attributable to a higher cardiac output, but increased capillarization and respiratory chain function in the muscle are also discussed. 32 Of note, VȮ 2 max can be increased by a diversity of training programs even in sedentary elderly participants, which in turn improves cognition, especially executive functions. 34 The mechanism by which VȮ 2 max is related to cognitive function is unclear. 35 Exercise is known to enhance cerebral blood flow, 36 capillary density, substrate exchange, and antioxidative mechanisms. 1 Some of the effect of VȮ 2 max on cognition might also be conveyed indirectly by counteracting depression in the elderly. 37 Although we found no evidence in the literature, we tentatively hypothesize that VȮ 2 max may also be indicative of oxygen utilization capacity in the brain as well.
The association between VȮ 2 max and cognition may be indirect, likely attributable to a more favorable vascular risk factor profile. In fact, high VȮ 2 max has been associated with reduced risk of cardiovascular disease, 38 insulin resistance, 39 and metabolic syndrome. 40 Our finding that adjustment for vascular risk factors attenuated the association between VȮ 2 max and motor skills supports this hypothesis.
There are several limitations to our study. The cross-sectional design, which allows measurement of cognition, exercise, and MRI only at a single time point, limits causal inference. Additional insight may be gained by longitudinal studies. Second, VȮ 2 max was not directly measured using spiroergometry, but calculated from heart rates obtained by exercise ECG. Third, we cannot entirely rule out residual confounding from unavailable lifestyle variables such as diet or physical activity.
Nevertheless, our study has multiple strengths. Above all, we benefit from an extensive phenotypic workup, including an array of cognitive tests and scores for all domains, the availability of MRI, as well as exercise ECG data. Another benefit is the large sample size and the homogeneous community-based elderly cohort.
Further interventional studies are needed to investigate the potential of cardiorespiratory fitness as a therapeutic option against cognitive decline in the elderly. It will be important to identify those individuals who, based on their risk factor profile, will benefit the most from intervention programs.
